Results 231 to 234 of about 4,101 (234)

Fixed-duration BTKi-venetoclax combinations in CLL: optimizing patient-centered care

Expert Review of Anticancer Therapy
Stefano Molica, David Allsup
openaire   +1 more source

The dual HCK/BTK inhibitor KIN-8194 impairs growth and integrin-mediated adhesion of BTKi-resistant mantle cell lymphoma

Leukemia
Annemieke Kuil, Sara J Buhrlage, Steven P Treon   +2 more
exaly  

HSR25-203: Cost-Effectiveness Evaluation of Bruton Tyrosine Kinase Inhibitor (BTKi) Treatments Among Medicare Patients With Chronic Lymphocytic Leukemia (CLL) in First-Line (1L) and Relapsed/Refractory (R/R) Settings

Journal of the National Comprehensive Cancer Network: JNCCN
exaly  

Title: SCOPING OUT CARDIOVASCULAR ASSESSMENT ON INITIATION AND SUBSEQUENT MONITORING DURING BTKI THERAPY, AN ERIC INITIATIVE

openaire   +1 more source